COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
SdK invites bondholders of Schlote Holding GmbH to an investors call on 1st of February 2024 at 3 pm (cet)
SdK invites bondholders of Schlote Holding GmbH to an investor call on 1st of February 2024 at 3 pm (cet). Bondholders will discuss the reduction in nominal value, maturity extension, and interest adjustments of the 2019/2024 bond. Lawyer Dr. Marc Liebscher to be appointed as joint representative -
COMMUNIQUÉ DE PRESSE
Nebeus Secures €250M Institutional Funding for Its Crypto Loan Offering
Nebeus launches €250M crypto-backed loan programme, offering secure & efficient service for corporate clients & individuals. Enhanced loan process provides liquidity within 2-7 days, leveraging crypto assets for financial opportunities -
COMMUNIQUÉ RÉGLEMENTÉ
Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 22/01/2024 tot 26/01/2024
Compagnie du Bois Sauvage heeft aangekondigd dat ze eigen aandelen heeft teruggekocht op de gereglementeerde markt van NYSE Euronext Brussel, volgens de machtigingen van de buitengewone algemene vergadering van 28 april 2021 -
COMMUNIQUÉ RÉGLEMENTÉ
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 22/01/2024 au 26/01/2024
La Compagnie du Bois Sauvage a annoncé le rachat d'actions propres effectué du 22/01/2024 au 26/01/2024, en accord avec l'autorisation de l'assemblée générale extraordinaire. Toutes les informations sont disponibles sur www.bois-sauvage.be -
COMMUNIQUÉ RÉGLEMENTÉ
Cie du Bois Sauvage: Buy back of own shares – week from 22/01/2024 to 26/01/2024
Cie du Bois Sauvage implemented the authorization of the extraordinary general meeting and disclosed the trading in own shares for the week from 22/01/2024 to 26/01/2024, buying back 3372 shares since October 2, 2023 -
COMMUNIQUÉ DE PRESSE
MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients
MindBio Therapeutics Corp. is nearing completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder. The company expects top line results to be announced in March 2024. MindBio is conducting trials with regulatory approvals for take-home use of a special form of LSD in microdoses, aiming to treat mental health conditions -
-
COMMUNIQUÉ DE PRESSE
Renewi plc: Trading Update
Renewi plc announces its results for the third quarter, with a challenging economic backdrop in key markets, partially offset by progress in margin initiatives. The company expects a stronger second-half performance amidst a weaker regional economic environment -
COMMUNIQUÉ DE PRESSE
Transaction in Own Shares
Nordea Bank Abp has completed the repurchase of its own shares in public trading, in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The company holds 5,605,138 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes
